Showing results (31-40 of 1,148) with videos related to
Sort By:
Pageof 115
Clinical Chemistry and Laboratory Medicine|June 16, 1999
Increased serum neopterin concentrations in patients with Alzheimer's diseaseF Leblhuber, J Walli, U Demel, et al.Immunobiology|April 25, 2000
Reduced pteridine derivatives induce apoptosis in human neuronal NT2/HNT cellsN Spöttl, B Wirleitner, G Böck, et al.Digestive Diseases and Sciences|August 29, 2000
Carbohydrate malabsorption syndromes and early signs of mental depression in femalesM Ledochowski, B Widner, B Sperner-Unterweger, et al.Clinical Chemistry and Laboratory Medicine|October 11, 2001
Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake?D Fuchs, M Jaeger, B Widner, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|May 23, 2000
Tryptophan degradation and immune activation in Alzheimer's diseaseB Widner, F Leblhuber, J Walli, et al.Advances in Experimental Medicine and Biology|March 18, 2000
Degradation of tryptophan in neurodegenerative disordersB Widner, F Leblhuber, J Walli, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 18, 2002
Moderate hyperhomocysteinaemia and immune activation in Parkinson's diseaseB Widner, F Leblhuber, B Frick, et al.Clinical Chemistry|November 2, 1999
Neopterin is an independent prognostic variable in females with breast cancerC Murr, A Bergant, M Widschwendter, et al.European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|September 1, 1994
Neopterin production and tryptophan degradation in acute Lyme neuroborreliosis versus late Lyme encephalopathyT Gasse, C Murr, P Meyersbach, et al.International Journal of Cancer|October 7, 1998
Neopterin as a prognostic parameter in patients with squamous-cell carcinomas of the oral cavityC Murr, J Berchtold, B Norer, et al.Pageof 115